Diagnostic Kits/Paper: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 31: Line 31:


== Forces affecting the GDx Industry ==
== Forces affecting the GDx Industry ==
* Revolutionary technical advances
=== Revolutionary technical advances ===
* Regulatory process
===  Regulatory process ===
* payer system (public & private insurance)
===  payer system (public & private insurance) ===
* Intellectual Property
===  Intellectual Property ===
** Case Law
==== Case Law ====
** Proposed Alternative Protection Schemes
====  Proposed Alternative Protection Schemes ====
*** Patent Pools
* Patent Pools
*** Patent Clearing Houses
* Patent Clearing Houses
* Licensing
====  Licensing ====
** Licensing Approaches
* Licensing Approaches
** Compulsory Licensing
* Compulsory Licensing
** Licensing Behavior
* Licensing Behavior


== Existing and Evolving GDx Models ==
== Existing and Evolving GDx Models ==

Revision as of 12:49, 3 December 2009

Are patents clogging the pipeline: The effects of intellectual property on commercialization and access to genetic diagnostics
(A Summary Paper of our Research to date)
By Carolina Rossini, Andrew Clearwater, and Mackenzie Cowell

Last Draft: December 3, 2009

Introduction

Description of the GDx Market

Defining Genetic Diagnostics

from Educational_Materials#Field_Definition

Brief History of GDx and Related Technology

  • chemical patents at turn of century (see Palombi's work)

Overview of IP Landscape

from Overview_of_Economics_of_Intellectual_Property_in_Kits see overview]

Patent Protection

Bayh-Dole

Licensing

When IP Does and Does Not Work Effectively

Our Research Questions

Our Methodology

Forces affecting the GDx Industry

Revolutionary technical advances

Regulatory process

payer system (public & private insurance)

Intellectual Property

Case Law

Proposed Alternative Protection Schemes

  • Patent Pools
  • Patent Clearing Houses

Licensing

  • Licensing Approaches
  • Compulsory Licensing
  • Licensing Behavior

Existing and Evolving GDx Models

Commercialization of Basic Research

  • Licensing of research to existing GDx company
  • Licensing of research to new GDx start-up
  • Usage of research in public domain by existing GDx company? (multiplex kits?)

Paths to Market

  • ASRs
  • Kits
  • DTC

Discussion

Conclusions

Bibliography